NBIX News
Neurocrine Biosciences Presents Real-World Evidence Mapping the Lifelong, Evolving Impact of Classic Congenital Adrenal Hyperplasia
Neurocrine Biosciences Presents Real-World Evidence Mapping the Lifelong, Evolving Impact of Classic Congenital Adrenal Hyperplasia Neurocrine Biosciences Presents Real-World Evidence Mapping the Lifelong, Evolving Impact of Classic Congenital Adrenal HyperplasiaPR NewswireSAN DIEGO, Oct. 16, 2026...
PR Newswire
Neurocrine Biosciences Presents Real-World Evidence Mapping the Lifelong, Evolving Impact of Classic Congenital Adrenal Hyperplasia
Neurocrine Biosciences Presents Real-World Evidence Mapping the Lifelong, Evolving Impact of Classic Congenital Adrenal Hyperplasia Neurocrine Biosciences Presents Real-World Evidence Mapping the Lifelong, Evolving Impact of Classic Congenital Adrenal HyperplasiaPR NewswireSAN DIEGO, Oct. 16, 2026...
PR Newswire
Why Neurocrine Biosciences (NBIX) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
NBIX vs. SDZNY: Which Stock Should Value Investors Buy Now?
NBIX vs. SDZNY: Which Stock Is the Better Value Option?
Zacks
Why Neurocrine Biosciences (NBIX) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2026 Financial Results
Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2026 Financial Results Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2026 Financial ResultsPR NewswireSAN DIEGO, Oct. 12, 2026Conference Call and Webcast Scheduled for Monday, November 2SAN...
PR Newswire
4 CNS Drug Stocks Worth Watching This World Mental Health Day
AXSM, NBIX, ALKS and ACAD are advancing CNS treatments for mental health disorders, with growing product sales, pipeline progress and new growth opportunities.
Zacks
Neurocrine Biosciences to Present Research Advancing Understanding of Prader-Willi Syndrome and Real-World Experience with VYKAT XR (diazoxide choline) at Foundation for Prader-Willi Research Symposium & Family Conference
Neurocrine Biosciences to Present Research Advancing Understanding of Prader-Willi Syndrome and Real-World Experience with VYKAT XR (diazoxide choline) at Foundation for Prader-Willi Research Symposium & Family Conference Neurocrine Biosciences to Present Research Advancing Understanding of...
PR Newswire
Neurocrine Biosciences Appoints Eiry W. Roberts, M.D., as Chief Medical Officer
Neurocrine Biosciences Appoints Eiry W. Roberts, M.D., as Chief Medical Officer Neurocrine Biosciences Appoints Eiry W. Roberts, M.D., as Chief Medical OfficerPR NewswireSAN DIEGO, Sept. 28, 2026 SAN DIEGO, Sept. 28, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced...
PR Newswire
Neurocrine Biosciences to Present at Upcoming Investor Conferences in September
Neurocrine Biosciences to Present at Upcoming Investor Conferences in September Neurocrine Biosciences to Present at Upcoming Investor Conferences in September PR Newswire SAN DIEGO, Sept. 2, 2026 SAN DIEGO, Sept. 2, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced...
PR Newswire
Neurocrine's Crenessity Gains Ground in CAH: How Far Can Sales Go?
NBIX's Crenessity gains rapid traction in CAH, with sales soaring and low patient penetration leaving room for growth.
Zacks